الصفحة الرئيسية>>Signaling Pathways>> DNA Damage/DNA Repair>> DNA/RNA Synthesis>>2',3'-Dideoxyadenosine 5'-triphosphate

2',3'-Dideoxyadenosine 5'-triphosphate (Synonyms: 2',3'-Dideoxyadenosine 5'-triphosphate)

رقم الكتالوجGC42061

2'؛ 3'؛ -Dideoxyadenosine 5'؛ -Triphosphate (2'؛، 3'؛ -Dideoxyadenosine 5'؛ -triphosphate88) ، مستقلب نشط من 27773973988 ؛ مثبّط

Products are for research use only. Not for human use. We do not sell to patients.

2',3'-Dideoxyadenosine 5'-triphosphate التركيب الكيميائي

Cas No.: 24027-80-3

الحجم السعر المخزون الكميّة
100μL(10 mM in  water)
182٫00
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com


مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

2',3'-Dideoxyadenosine 5'-triphosphate (ddATP) is an in vitro inhibitor of reverse transcriptases from retroviruses, including HIV-1 and visna (Kis = 20 and 37 nM, respectively). It also blocks, in vitro, mammalian and bacterial DNA polymerases. ddATP, produced intracellularly by the phosphorylation of exogenously supplied 2',3'-dideoxyadenosine, competes with dATP, resulting in chain termination. Because of this activity, dideoxynucleoside 5'-triphosphates, including ddATP, are used to terminate chain extension produced by the Taq polymerase used in polymerase chain reactions. It is also an antagonist of the purinergic receptor P2X2/3 (pIC50 = 6.5).

مراجعات

Review for 2',3'-Dideoxyadenosine 5'-triphosphate

Average Rating: 5 ★★★★★ (Based on Reviews and 15 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for 2',3'-Dideoxyadenosine 5'-triphosphate

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.